Dual Service Advantage KMI operates two complementary service lines: clinical diagnostic testing for clinics and research testing for CROs, universities, and the biotech sector, under a CLIA certified facility, enabling a single partner for both patient diagnostics and research data needs.

Prestigious Partnerships The company has a track record of supplying data to Ivy League institutions and major hospitals, signaling credibility and a pipeline for expanding into additional academic and government research programs.

Customization Excellence Starting as a highly tailored testing service, KMI emphasizes bespoke panels and flexible workflows, which can be positioned as a differentiator to win high complexity projects from researchers and clinics.

Growth via Outsourcing With a lean team and established client relationships, KMI can scale engagement through contracted lab services, expanding test menus and capacity to meet increasing demand from CROs and healthcare providers.

Regulatory Credibility CLIA certification adds regulatory credibility for research data, making KMI an attractive partner for clients who require validated, industry standard results for publications, submissions, or regulatory considerations.